FDA's New Generic Drug Safety Labeling Rule

Webinar

FDA's Generic Drug Safety Labeling Rule

Your office, Dec. 9, 2013

Benefits

Here’s a suggested list of potential participants from your organization:

 

  • Regulatory affairs and compliance officers
  • Pharmacovigilance and drug safety personnel and managers
  • Medical affairs/medical monitors and physicians
  • CCDS writers and reviewers
  • Drug safety scientists/risk management specialists
  • Consultants/service providers
  • Executive management